BusinessLyfebulb Partners with UnitedHealth Group to Support Patient-Driven Innovations for People with Inflammatory Bowel DiseaseBy Nasdaq OMXJan 17, 2018, 1:02 PM UTC
BusinessVitality Biopharma Submits Orphan Drug Designation Request to FDA for Flagship THC Prodrug VITA-100By Nasdaq OMXJan 17, 2018, 1:01 PM UTC
BusinessVitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THCBy Nasdaq OMXJan 3, 2018, 1:31 PM UTC
BusinessEconomic Optimism Marks One Year in Positive Territory, the Longest Stretch in More Than a Decade, and Continues to Climb According to September IBD/TIPP PollBy Nasdaq OMXSep 7, 2017, 2:00 PM UTC
BusinessCrownBio Launches Innovative Inflammatory Disease Models to Advance Pre-Clinical ResearchBy Nasdaq OMXAug 1, 2017, 12:00 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:28 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
BusinessAtlantic Healthcare develops tablet formulations of alicaforsen to treat Crohn's disease and Ulcerative ColitisBy Nasdaq OMXMay 30, 2017, 12:27 PM UTC
